The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients

The treatment for chronic active antibody-mediated rejection (CAMR) remains controversial. We investigated the efficacy of rituximab (RTX) and intravenous immunoglobulin (IVIg) for CAMR. Eighteen patients with CAMR were treated with RTX (375 mg/m(2)) and IVIg (0.4 g/kg) for 4 days. The efficacy of R...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Gun Hee, Yun, Jintak, Hong, Yu Ah, Khvan, Marina, Chung, Byung Ha, Choi, Bum Soon, Park, Cheol Whee, Choi, Yeong Jin, Kim, Yong-Soo, Yang, Chul Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987969/
https://www.ncbi.nlm.nih.gov/pubmed/24741626
http://dx.doi.org/10.1155/2014/828732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987969/
https://www.ncbi.nlm.nih.gov/pubmed/24741626
http://dx.doi.org/10.1155/2014/828732

Ejemplares similares